• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自适应癌症治疗中的阈值意识。

Threshold-awareness in adaptive cancer therapy.

机构信息

Center for Applied Mathematics, Cornell University, Ithaca, New York, United States of America.

Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, Ohio, United States of America.

出版信息

PLoS Comput Biol. 2024 Jun 14;20(6):e1012165. doi: 10.1371/journal.pcbi.1012165. eCollection 2024 Jun.

DOI:10.1371/journal.pcbi.1012165
PMID:38875286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11210878/
Abstract

Although adaptive cancer therapy shows promise in integrating evolutionary dynamics into treatment scheduling, the stochastic nature of cancer evolution has seldom been taken into account. Various sources of random perturbations can impact the evolution of heterogeneous tumors, making performance metrics of any treatment policy random as well. In this paper, we propose an efficient method for selecting optimal adaptive treatment policies under randomly evolving tumor dynamics. The goal is to improve the cumulative "cost" of treatment, a combination of the total amount of drugs used and the total treatment time. As this cost also becomes random in any stochastic setting, we maximize the probability of reaching the treatment goals (tumor stabilization or eradication) without exceeding a pre-specified cost threshold (or a "budget"). We use a novel Stochastic Optimal Control formulation and Dynamic Programming to find such "threshold-aware" optimal treatment policies. Our approach enables an efficient algorithm to compute these policies for a range of threshold values simultaneously. Compared to treatment plans shown to be optimal in a deterministic setting, the new "threshold-aware" policies significantly improve the chances of the therapy succeeding under the budget, which is correlated with a lower general drug usage. We illustrate this method using two specific examples, but our approach is far more general and provides a new tool for optimizing adaptive therapies based on a broad range of stochastic cancer models.

摘要

尽管适应性癌症疗法在将进化动力学纳入治疗计划方面显示出了一定的前景,但癌症进化的随机性很少被考虑到。各种随机扰动源会影响异质肿瘤的进化,从而使任何治疗策略的性能指标也变得随机。在本文中,我们提出了一种在随机肿瘤动力学下选择最佳适应性治疗策略的有效方法。目标是提高治疗的累积“成本”,即药物使用总量和总治疗时间的组合。由于在任何随机环境中,成本也是随机的,因此我们最大化达到治疗目标(肿瘤稳定或根除)的概率,而不会超过预定的成本阈值(或“预算”)。我们使用一种新的随机最优控制公式和动态规划来找到这种“阈值感知”的最优治疗策略。我们的方法可以为一系列阈值同时计算这些策略,从而实现一种高效的算法。与在确定性环境下被证明是最优的治疗方案相比,新的“阈值感知”策略显著提高了在预算范围内治疗成功的机会,这与较低的一般药物使用量相关。我们使用两个具体的例子来说明这种方法,但我们的方法更加通用,为基于广泛的随机癌症模型优化适应性治疗提供了一种新的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a16/11210878/c6a823207cbc/pcbi.1012165.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a16/11210878/08af44277059/pcbi.1012165.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a16/11210878/481768398674/pcbi.1012165.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a16/11210878/dbfc9d837f68/pcbi.1012165.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a16/11210878/f2c6babe8fb4/pcbi.1012165.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a16/11210878/0af3b9132a1a/pcbi.1012165.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a16/11210878/32b14309c969/pcbi.1012165.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a16/11210878/c6a823207cbc/pcbi.1012165.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a16/11210878/08af44277059/pcbi.1012165.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a16/11210878/481768398674/pcbi.1012165.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a16/11210878/dbfc9d837f68/pcbi.1012165.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a16/11210878/f2c6babe8fb4/pcbi.1012165.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a16/11210878/0af3b9132a1a/pcbi.1012165.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a16/11210878/32b14309c969/pcbi.1012165.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a16/11210878/c6a823207cbc/pcbi.1012165.g007.jpg

相似文献

1
Threshold-awareness in adaptive cancer therapy.自适应癌症治疗中的阈值意识。
PLoS Comput Biol. 2024 Jun 14;20(6):e1012165. doi: 10.1371/journal.pcbi.1012165. eCollection 2024 Jun.
2
Optimizing adaptive cancer therapy: dynamic programming and evolutionary game theory.优化适应性癌症治疗:动态规划和进化博弈论。
Proc Biol Sci. 2020 Apr 29;287(1925):20192454. doi: 10.1098/rspb.2019.2454. Epub 2020 Apr 22.
3
Numerical Approach to Spatial Deterministic-Stochastic Models Arising in Cell Biology.细胞生物学中出现的空间确定性-随机模型的数值方法。
PLoS Comput Biol. 2016 Dec 13;12(12):e1005236. doi: 10.1371/journal.pcbi.1005236. eCollection 2016 Dec.
4
BioSimulator.jl: Stochastic simulation in Julia.BioSimulator.jl:Julia 中的随机模拟。
Comput Methods Programs Biomed. 2018 Dec;167:23-35. doi: 10.1016/j.cmpb.2018.09.009. Epub 2018 Oct 10.
5
Mutation-selection dynamics and error threshold in an evolutionary model for Turing machines.图灵机进化模型中的突变-选择动力学与错误阈值
Biosystems. 2012 Jan;107(1):18-33. doi: 10.1016/j.biosystems.2011.08.003. Epub 2011 Aug 31.
6
Parameter inference for discretely observed stochastic kinetic models using stochastic gradient descent.使用随机梯度下降对离散观测的随机动力学模型进行参数推断。
BMC Syst Biol. 2010 Jul 21;4:99. doi: 10.1186/1752-0509-4-99.
7
Hybrid deterministic/stochastic simulation of complex biochemical systems.复杂生化系统的混合确定性/随机模拟
Mol Biosyst. 2017 Nov 21;13(12):2672-2686. doi: 10.1039/c7mb00426e.
8
A novel evolutionary drug scheduling model in cancer chemotherapy.一种癌症化疗中的新型进化药物调度模型。
IEEE Trans Inf Technol Biomed. 2006 Apr;10(2):237-45. doi: 10.1109/titb.2005.859888.
9
A comparison of deterministic and stochastic approaches for sensitivity analysis in computational systems biology.计算系统生物学中敏感性分析的确定性和随机方法比较。
Brief Bioinform. 2020 Mar 23;21(2):527-540. doi: 10.1093/bib/bbz014.
10
Adaptive tree-based search for stochastic simulation algorithm.用于随机模拟算法的基于自适应树的搜索
Int J Comput Biol Drug Des. 2014;7(4):341-57. doi: 10.1504/IJCBDD.2014.066542. Epub 2014 Dec 25.

引用本文的文献

1
Modeling critical dosing strategies for stromal-induced resistance to cancer therapy.构建基质诱导的癌症治疗耐药性的关键给药策略模型。
NPJ Syst Biol Appl. 2025 Feb 6;11(1):16. doi: 10.1038/s41540-025-00495-0.

本文引用的文献

1
Understanding cellular growth strategies via optimal control.通过最优控制理解细胞生长策略。
J R Soc Interface. 2023 Jan;20(198):20220744. doi: 10.1098/rsif.2022.0744. Epub 2023 Jan 4.
2
Measuring competitive exclusion in non-small cell lung cancer.测量非小细胞肺癌中的竞争排斥。
Sci Adv. 2022 Jul;8(26):eabm7212. doi: 10.1126/sciadv.abm7212. Epub 2022 Jul 1.
3
Drug-induced resistance evolution necessitates less aggressive treatment.药物诱导的耐药性进化需要采取不那么激进的治疗方法。
PLoS Comput Biol. 2021 Sep 23;17(9):e1009418. doi: 10.1371/journal.pcbi.1009418. eCollection 2021 Sep.
4
A general theory of coexistence and extinction for stochastic ecological communities.随机生态群落共存与灭绝的一般理论。
J Math Biol. 2021 May 7;82(6):56. doi: 10.1007/s00285-021-01606-1.
5
Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020.2006 - 2020年美国癌症患者中基因组靶向肿瘤药物的适用率和反应率的最新估计。
Ann Oncol. 2021 Jul;32(7):926-932. doi: 10.1016/j.annonc.2021.04.003. Epub 2021 Apr 20.
6
Optimal control to reach eco-evolutionary stability in metastatic castrate-resistant prostate cancer.最优控制以达到转移性去势抵抗性前列腺癌的生态进化稳定。
PLoS One. 2020 Dec 8;15(12):e0243386. doi: 10.1371/journal.pone.0243386. eCollection 2020.
7
Persistence as an Optimal Hedging Strategy.作为一种最优套期保值策略的持久性
Biophys J. 2021 Jan 5;120(1):133-142. doi: 10.1016/j.bpj.2020.11.2260. Epub 2020 Nov 28.
8
Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures.对靶向治疗的抵抗是一种多因素的、逐渐适应抑制剂特异性选择压力的过程。
Nat Commun. 2020 May 14;11(1):2393. doi: 10.1038/s41467-020-16212-w.
9
Optimizing adaptive cancer therapy: dynamic programming and evolutionary game theory.优化适应性癌症治疗:动态规划和进化博弈论。
Proc Biol Sci. 2020 Apr 29;287(1925):20192454. doi: 10.1098/rspb.2019.2454. Epub 2020 Apr 22.
10
Towards Multidrug Adaptive Therapy.迈向多药自适应治疗。
Cancer Res. 2020 Apr 1;80(7):1578-1589. doi: 10.1158/0008-5472.CAN-19-2669. Epub 2020 Jan 16.